Evidence map›Paper›PMID 31672665›Full record

ArticleAntiviral research2019

Serial real-time RT-PCR and serology measurements substantially improve Zika and Dengue virus infection classification in a co-circulation area.

Aurelie Gouel-Cheron, Keith Lumbard, Sally Hunsberger, Fernando J Arteaga-Cabello, John Beigel, Pablo F Belaunzarán-Zamudio, Sandra Caballero-Sosa, Kenia Escobedo-López, Violeta Ibarra-González, José Gabriel Nájera-Cancino and 5 more

Registry-linked trialOpen access · bronzeAbstract readMulticenter Study
In one paragraph

Article in Antiviral research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02831699 (The Evaluation of Potential Zika, Chikungunya, and Dengue Infections in Mexico), which is not on this map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02831699 completednot on this map

The Evaluation of Potential Zika, Chikungunya, and Dengue Infections in Mexico (Zik01)

TypeobservationalSponsorMexican Emerging Infectious Diseases Clinical Research NetworkRan2016 to 2019Enrolled600ConditionsZika Virus Disease (Disorder), Dengue, Chikungunya
3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Ocular Manifestations of Flavivirus Infections.Pathogens (Basel, Switzerland) · 2023
    Review
  3. Article
  4. Observational
  5. Observational
  6. Article
  7. Article
  8. Review
  9. Article
  10. The diagnosis of pandemic coronavirus pneumonia: A review of radiology examination and laboratory test.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology · 2020
    Review
  11. A unique immune signature of serum cytokine and chemokine dynamics in patients with Zika virus infection from a tropical region in Southern Mexico.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 3 countries.

Aurelie Gouel-CheronBiostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institute of Health, Rockville, MD, USA; Département d'Anesthésie et Réanimation Chirurgicale, Groupe Hospitalier Bichat Claude Bernard, Université de Paris, Assistance Publique Hôpitaux de Paris, Paris, France; Unit of Antibodies in Therapy and Pathology, Pasteur Institut, UMR 1222 INSERM, Paris, France. Electronic address: aurelie.gouel@aphp.fr.
Keith LumbardBiostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institute of Health, Rockville, MD, USA. Electronic address: keith.lumbard@nih.gov.
Sally HunsbergerBiostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institute of Health, Rockville, MD, USA. Electronic address: sally.hunsberger@nih.gov.
Fernando J Arteaga-CabelloDepartamento de Infectología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico. Electronic address: ferartc@gmail.com.
John BeigelNational Institute of Allergy and Infectious Diseases, Bethesda, MD, USA. Electronic address: jbeigel@niaid.nih.gov.
Pablo F Belaunzarán-ZamudioDepartamento de Infectología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico. Electronic address: p.belaunz@infecto.mx.
Sandra Caballero-SosaClínica Hospital Dr. Roberto Nettel Flores, Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado, Tapachula, Chiapas, Mexico. Electronic address: sandracaballero@redmexei.mx.
Kenia Escobedo-LópezDepartamento de Infectología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico. Electronic address: kemesk@yahoo.com.
Violeta Ibarra-GonzálezDepartamento de Infectología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico. Electronic address: violetaig@gotmail.com.
José Gabriel Nájera-CancinoHospital Regional de Alta Especialidad Ciudad Salud, Tapachula, Chiapas, Mexico. Electronic address: gabriel.najera.78@gmail.com.
Héctor Armando Rincón-LeónUnidad de Medicina Familiar No.11, Instituto Mexicano del Seguro Social, Tapachula, Chiapas, Mexico. Electronic address: hector.rinconl@imss.gob.mx.
Emilia Ruiz-HernándezHospital General de Tapachula, Tapachula, Chiapas, Mexico. Electronic address: dramilieruiz@gmail.com.
Jesús Sepúlveda-DelgadoHospital Regional de Alta Especialidad Ciudad Salud, Tapachula, Chiapas, Mexico. Electronic address: jesussd52@gmail.com.
Karina Trujillo-MurilloHospital Regional de Alta Especialidad Ciudad Salud, Tapachula, Chiapas, Mexico. Electronic address: kary_trujillo@hotmail.com.
Guillermo Ruiz-PalaciosDepartamento de Infectología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico. Electronic address: gmrps@unam.mx.
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán · MXHospitales Regionales de Alta Especialidad · MXNational Institute of Allergy and Infectious Diseases · USAssistance Publique – Hôpitaux de Paris · FRInstitute for Social Security and Services for State Workers · MXMexican Social Security Institute · MXUniversidad del Tacana · MX

Funding

NCI NIH HHS HHSN261200800001E
6 · The paper itself

Abstract

backgroundReal-time RT-PCR (Reverse Transcriptase Polymerase Chain Reaction) is considered the gold standard for Zika virus (ZIKV) infection diagnosis, despite its low sensitivity. Diagnosis using recommended serologic cutoffs in co-circulating Flaviviruses areas maybe inadequate due to in-vitro cross-reactivities of Flaviviruses-specific antibodies. We evaluated Zika diagnosis in symptomatic patients using serial RT-PCR and develop a classification model using serial Dengue virus (DENV) and ZIKV serologies.

methodsA prospective longitudinal multicentric study in Southern Mexico (NCT02831699) enrolled symptomatic and non-symptomatic participants. In the classification model, true positives were symptomatic (using a modified World Health Organization/Pan American Health Organization definition) with RT-PCR positive for ZIKV or DENV. True negatives were non-symptomatic with negative RT-PCR. Serial serology measurements were used to predict disease status.

resultsAnalyzing ZIKV and DENV RT-PCR at 3 timepoints between days 3 and 13 of symptom onset detected 25% more cases than a single RT-PCR analysis between day 0 and 6. When considering sensitivity and specificity together, the serial serology model predicted all categories of disease and negatives better than manufactures cutoffs. Their cutoffs optimized sensitivity or specificity but not both.

conclusionsWe demonstrated the importance of serial RT-PCR and antibody measurements to diagnose arbovirus infection in symptomatic patients living in regions with co-circulating flaviviruses.

Indexed as

AdultAntibodiesDengueDengue VirusEnzyme-Linked Immunosorbent AssayFemaleHumansLongitudinal StudiesMaleProspective StudiesReal-Time Polymerase Chain ReactionReverse Transcriptase Polymerase Chain ReactionSensitivity and SpecificityViremiaYoung AdultZika VirusAntibodiesAntibodiesDengue virusKineticsReverse transcriptase polymerase chain reactionViremiaZika virus

Identifiers

PMID31672665
PMCPMC6901092
OpenAlexW2982383746

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.